Israeli Cannabinoid Biotech Therapix IPOs on NASDAQ


therapix bio
Therapix Biosciences Ltd. Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing

TEL AVIV, Israel, March 22, 2017 /PRNewswire/ —

Therapix Biosciences Ltd. (NASDAQ: TRPX) (TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced the pricing of its

... read more at: https://www.newcannabisventures.com/israeli-cannabinoid-biotech-therapix-ipos-on-nasdaq/

by